Drugs and Therapy Bulletin
Drugs & Therapy Bulletin is a monthly publication by the Department of Pharmacy Services and the Pharmacy and Therapeutics Committee of UF Health. Each month, this newsletter highlights the most important drug topics that challenge our department.
The contents of our most recent volumes are listed below. Please click on the desired issue to view the .pdf document. For older issues, please visit our archive page.
2014 Volume 28
October, Number 6
- Formulary Update
- Medication Safety Corner: High Alert Medications
- Bedside Barcode Medication Administration – Scanning the Horizon
June/July, Number 4
- Formulary Update
- FDA Removes High-dose Acetaminophen in Combination Products
May, Number 3
- Formulary Update
- ACC/AHA New Cholesterol Guidelines
March, Number 2
- Formulary Update
- Buprenorphine Ordering at UF Health Shands Hospital
- FDA Lifts Restrictions on Rosiglitazone (Avandia®)
February, Number 1
- Formulary Update
- Insulin Pen vs. Insulin Vial Use: Balancing the Risks
2013 Volume 27
December, Number 11
- Formulary Update
- Re-dosing of Reversal Agents in the Inpatient Setting
November, Number 10
- Formulary Update
- Patient’s Own Medication in the Inpatient Setting
- Fearing the Fluoroquinolones
- 2013 Annual Index
October, Number 9
- Formulary Update
- Oral Contraceptive Use in the Inpatient Setting
- Resistant to Change: Antimicrobial Resistance in 2013
August/September, Number 8
- Formulary Update
- News: Factor in the criteria
- A New Plan for Plan B
July, Number 7
- Formulary Update
- Pay for Delay (generics)
- Editorial Change
June, Number 6
- Formulary Update
- How do I pronounce generic drug names?
May, Number 5
- Formulary Update
- The Route Less Traveled
- High-priority, Restricted-distribution drugs
April, Number 4
- Formulary Update
- Formulary Categories
- A New Online Formulary
- Nursing’s Medication and Administration Policy
March, Number 3
- Formulary Update
- Why isn’t hydrocodone listed in the Formulary?
- Alternatives when an NSAID fails?
February, Number 2
- Formulary Update
- Drug Dosing in Renal Impairment
- New Drugs in 2012
January, Number 1
- Formulary Update
- Why we still use animal products
- New C. difficile treatment algorithm endorsed
2012 Volume 26
November/December, Number 10
- Formulary Update
- Delete codeine from the Formulary?
- Compounding pharmacies and fungal meningitis
- 2012 Annual index
October, Number 9
- Formulary Update
- Oral Contraceptives and Thromboembolic Risk
- Medication Safety Subcommittee
- CYP2C19 Reporting Changes
August/September, Number 8
- Formulary Update
- Can dabigatran CAUSE clots?
July, Number 7
- Formulary Update
- Medicaid restricts oxycodone prescribing for children
- Should the inpatient use of TNF-alpha drugs be restricted?
June, Number 6
- Formulary Update
- Don’t get burned: Use sunscreen appropriately
May, Number 5
- Formulary Update
- Updated pharmacokinetic consult policy
- Mandatory Oral Hypotensive Administration Instructions
- Anticoagulation Management at Shands at UF
April, Number 4
- Formulary Update
- Update on Drug Shortages
- Is the PDR Obsolete?
March, Number 3
- Formulary Update
- Opioid Prescribing in “Naive” or “Tolerant” Patients
- Using Epic to Document Criteria for Use
- What’s all the hype…about hyperglycemia?
February, Number 2
- Formulary Update
- New Drugs in 2011
- Pardon My Language: What is PML?
- New Personalized Medicine Subcommittee
January, Number 1
- Formulary Update
- Three Routes of Acetaminophen:
Three Ways to Achieve the Same Result - Cardiovascular Drug-Induced DM